drugset / Trial / NCT02369211

Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV)

NCT02369211 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To examine pharmacoeconomics of IV acetaminophen (Ofirmev). Specifically, to examine its potential to improve hospital efficiency and patient outcomes. The investigators compare the addition of IV acetaminophen versus placebo on postoperative anesthesia care unit recovery times, inpatient hospital length of stay (LOS), postoperative pain scores, consumption of opiates as rescue agents and side effects among patients undergoing robotic-assisted laparoscopic prostatectomy (RALP).

Timeline

Start
2015-09
Primary completion
2018-01
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1 g Intravenous

Indications